UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.680

Sortiert nach

Severe cutaneous adverse reactions to drugs

The Lancet (British edition), 2017-10, Vol.390 (10106), p.1996-2011

2017

Link zum Volltext

Verfügbarkeit prüfen

Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis

Journal of the American Academy of Dermatology, 2013-08, Vol.69 (2), p.173.e1

2013

Link zum Volltext

Verfügbarkeit prüfen

Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response

Journal of allergy and clinical immunology, 2015-08, Vol.136 (2), p.219-234

2015

Link zum Volltext

Verfügbarkeit prüfen

Relationship between the HLA-B1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

JAMA dermatology (Chicago, Ill.), 2013-09, Vol.149 (9), p.1025

2013

Link zum Volltext

Verfügbarkeit prüfen

Toxic epidermal necrolysis and Stevens-Johnson syndrome

Orphanet journal of rare diseases, 2010-12, Vol.5 (1), p.39-39, Article 39

2010

Link zum Volltext

Verfügbarkeit prüfen

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016

British journal of dermatology (1951), 2016-06, Vol.174 (6), p.1194-1227

2016

Link zum Volltext

Verfügbarkeit prüfen

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update

American journal of clinical dermatology, 2015-12, Vol.16 (6), p.475-493

2015

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management

Journal of the American Academy of Dermatology, 2019-04, Vol.80 (4), p.990-997

2019

Link zum Volltext

Verfügbarkeit prüfen

Mycoplasma-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: Case-control analysis of a cohort managed in a specialized center

Journal of the American Academy of Dermatology, 2022-04, Vol.86 (4), p.811-817

2022

Link zum Volltext

Verfügbarkeit prüfen

Stevens‐Johnson syndrome and toxic epidermal necrolysis‐like reactions to checkpoint inhibitors: a systematic review

International journal of dermatology, 2020-06, Vol.59 (6), p.e183-e188

2020

Link zum Volltext

Verfügbarkeit prüfen

HLA‐B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese

Epilepsia (Copenhagen), 2013-07, Vol.54 (7), p.1307-1314

2013

Link zum Volltext

Verfügbarkeit prüfen

Association between HLA‐B1502 and carbamazepine‐induced severe cutaneous adverse drug reactions in a Thai population

Epilepsia (Copenhagen), 2010-05, Vol.51 (5), p.926-930

2010

Link zum Volltext

Verfügbarkeit prüfen

The seven-fold rise in incidence of Stevens-Johnson syndrome & toxic epidermal necrolysis: Associations with COVID-19 and the vaccine

Burns, 2024-02, Vol.50 (1), p.87-92

2024

Link zum Volltext

Verfügbarkeit prüfen

Stevens‐Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System

Epilepsia (Copenhagen), 2018-12, Vol.59 (12), p.2318-2324

2018

Link zum Volltext

Verfügbarkeit prüfen

A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions

British journal of dermatology (1951), 2013-03, Vol.168 (3), p.555-562

2013

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 infection increases the development of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort analysis

Journal of the American Academy of Dermatology, 2024-06, Vol.90 (6), p.1300-1302

2024

Link zum Volltext

Verfügbarkeit prüfen

Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features

Journal of the American Academy of Dermatology, 2020-10, Vol.83 (4), p.1130-1143

2020

Link zum Volltext

Verfügbarkeit prüfen

IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting

Journal of investigative dermatology, 2022-11, Vol.142 (11), p.2920-2928.e5

2022

Link zum Volltext

Verfügbarkeit prüfen

Strong association between HLA-B5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

Pharmacogenetics and genomics, 2009-09, Vol.19 (9), p.704-709

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects

Scientific reports, 2020-03, Vol.10 (1), p.4353, Article 4353

2020

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitor associated epidermal necrosis, beyond SJS and TEN: a review of 98 cases

Archives of dermatological research, 2024-05, Vol.316 (6), p.233, Article 233

2024

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management

Journal of Cutaneous Medicine and Surgery, 2021-01, Vol.25 (1), p.59-76

2021

Link zum Volltext

Verfügbarkeit prüfen

The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome-Reply

JAMA dermatology (Chicago, Ill.), 2024-01, Vol.160 (1), p.117

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.680

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.158)
Mit Volltextzugriff
(1.638)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(2.647)
Stevens-Johnson Syndrome - Etiology
(1.872)
Science & Technology
(1.781)
Life Sciences & Biomedicine
(1.769)
Female
(1.368)
Male
(1.276)
Adult
(974)
Dermatology
(784)
Middle Aged
(757)
Stevens-Johnson Syndrome - Diagnosis
(654)
Toxic Epidermal Necrolysis
(525)
Aged
(506)
Stevens-Johnson Syndrome - Complications
(484)
Child
(482)
Biological And Medical Sciences
(470)
Medical Sciences
(469)
Stevens-Johnson Syndrome
(455)
Adolescent
(420)
Stevens-Johnson Syndrome - Pathology
(420)
Stevens-Johnson Syndrome - Therapy
(356)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Severe cutaneous adverse reactions to drugs

Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis

Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response

Relationship between the HLA-B1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

Toxic epidermal necrolysis and Stevens-Johnson syndrome

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update

Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management

Mycoplasma-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: Case-control analysis of a cohort managed in a specialized center

Stevens‐Johnson syndrome and toxic epidermal necrolysis‐like reactions to checkpoint inhibitors: a systematic review

HLA‐B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese

Association between HLA‐B1502 and carbamazepine‐induced severe cutaneous adverse drug reactions in a Thai population

The seven-fold rise in incidence of Stevens-Johnson syndrome & toxic epidermal necrolysis: Associations with COVID-19 and the vaccine

Stevens‐Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System

A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions

COVID-19 infection increases the development of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort analysis

Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features

IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting

Strong association between HLA-B5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians

Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects

Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study

Immune checkpoint inhibitor associated epidermal necrosis, beyond SJS and TEN: a review of 98 cases

Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management

The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome-Reply

Suchergebnisse filtern